Priv.-Doz. Dr. med.
Uwe Kordes
  • Senior physician
  • Medical Specialist in Pediatrics and Youth Medicine, with focus on Childrens' Hematology and Oncology
Working area

Location

O47 , 1st Floor, Room number 01.1.029.1
Languages
German (Mother tongue)
English

Areas of expertise

Publications

2023

Germ Cell Maintenance and Sustained Testosterone and Precursor Hormone Production in Human Prepubertal Testis Organ Culture with Tissues from Boys 7 Years+ under Conditions from Adult Testicular Tissue
Aden N, Bleeke M, Kordes U, Brunne B, Holstermann B, Biemann R, Ceglarek U, Soave A, Salzbrunn A, Schneider S, Kopylow K
CELLS-BASEL. 2023;12(3):.

Phase II Trial of Dabrafenib Plus Trametinib in Relapsed/Refractory BRAF V600–Mutant Pediatric High-Grade Glioma
Hargrave D, Terashima K, Hara J, Kordes U, Upadhyaya S, Sahm F, Bouffet E, Packer R, Witt O, Sandalic L, Kieloch A, Russo M, Cohen K
J CLIN ONCOL. 2023;41(33):5174-5183.

Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndrome
Kolodziejczak A, Guerrini-Rousseau L, Planchon J, Ecker J, Selt F, Mynarek M, Obrecht D, Sill M, Autry R, Zhao E, Hirsch S, Amouyal E, Dufour C, Ayrault O, Torrejon J, Waszak S, Ramaswamy V, Pentikainen V, Demir H, Clifford S, Schwalbe E, Massimi L, Snuderl M, Galbraith K, Karajannis M, Hill K, Li B, Walsh M, White C, Redmond S, Loizos L, Jakob M, Kordes U, Schmid I, Hauer J, Blattmann C, Filippidou M, Piccolo G, Scheurlen W, Farrag A, Grund K, Sutter C, Pietsch T, Frank S, Schewe D, Malkin D, Ben-Arush M, Sehested A, Wong T, Wu K, Liu Y, Carceller F, Mueller S, Stoller S, Taylor M, Tabori U, Bouffet E, Kool M, Sahm F, von Deimling A, Korshunov A, von Hoff K, Kratz C, Sturm D, Jones D, Rutkowski S, van Tilburg C, Witt O, Bougeard G, Pajtler K, Pfister S, Bourdeaut F, Milde T
NEURO-ONCOLOGY. 2023;25(12):2273-2286.

Rhabdoid tumors in patients conceived following ART: is there an association?
Nemes K, Benesch M, Kolarova J, Johann P, Hasselblatt M, Thomas C, Bens S, Glaser S, Ammerpohl O, Liaugaudiene O, Sadeghipour A, von der Weid N, Schmid I, Gidding C, Erdreich-Epstein A, Khurana C, Ebetsberger-Dachs G, Lemmer A, Khatib Z, Hernández Marqués C, Pears J, Quehenberger F, Kordes U, Vokuhl C, Gerss J, Schwarz H, Bison B, Biegel J, Siebert R, Frühwald M
HUM REPROD. 2023;38(10):2028-2038.

Generalized Infantile Myofibromatosis with Extensive Small Bowel Involvement in a Neonate
Schubert J, Wößmann W, Königs I, Clauditz T, Kordes U, Reinshagen K
Z GEBURTSH NEONATOL. 2023;227(3):231-235.

Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology
Sturm D, Capper D, Andreiuolo F, Gessi M, Kölsche C, Reinhardt A, Sievers P, Wefers A, Ebrahimi A, Suwala A, Gielen G, Sill M, Schrimpf D, Stichel D, Hovestadt V, Daenekas B, Rode A, Hamelmann S, Previti C, Jäger N, Buchhalter I, Blattner-Johnson M, Jones B, Warmuth-Metz M, Bison B, Grund K, Sutter C, Hirsch S, Dikow N, Hasselblatt M, Schüller U, Gerber N, White C, Buntine M, Kinross K, Algar E, Hansford J, Gottardo N, Hernáiz Driever P, Gnekow A, Witt O, Müller H, Calaminus G, Fleischhack G, Kordes U, Mynarek M, Rutkowski S, Frühwald M, Kramm C, von Deimling A, Pietsch T, Sahm F, Pfister S, Jones D
NAT MED. 2023;29(4):917-926.

2022

Spatial molecular profiling of a central nervous system low-grade diffusely infiltrative tumour with INI1 deficiency featuring a high-grade atypical teratoid/rhabdoid tumour component
Dottermusch M, Schumann Y, Kordes U, Hasselblatt M, Neumann J
NEUROPATH APPL NEURO. 2022;48(3):e12777.

ATRT-SHH comprises three molecular subgroups with characteristic clinical and histopathological features and prognostic significance
Federico A, Thomas C, Miskiewicz K, Woltering N, Zin F, Nemes K, Bison B, Johann P, Hawes D, Bens S, Kordes U, Albrecht S, Dohmen H, Hauser P, Keyvani K, van Landeghem F, Lund E, Scheie D, Mawrin C, Monoranu C, Parm Ulhøi B, Pietsch T, Reinhard H, Riemenschneider M, Sehested A, Sumerauer D, Siebert R, Paulus W, Frühwald M, Kool M, Hasselblatt M
ACTA NEUROPATHOL. 2022;143(6):697-711.

Low-grade diffusely infiltrative tumour (LGDIT), SMARCB1-mutant: A clinical and histopathological distinct entity showing epigenetic similarity with ATRT-MYC
Hasselblatt M, Thomas C, Federico A, Bens S, Hellström M, Casar-Borota O, Kordes U, Neumann J, Dottermusch M, Rodriguez F, Lo A, Cheng S, Hendson G, Hukin J, Hartmann C, Koch A, Capper D, Siebert R, Paulus W, Nemes K, Johann P, Frühwald M, Kool M
NEUROPATH APPL NEURO. 2022;48(4):e12797.

SMARCB1-deficient and SMARCA4-deficient Malignant Brain Tumors With Complex Copy Number Alterations and TP53 Mutations May Represent the First Clinical Manifestation of Li-Fraumeni Syndrome
Hasselblatt M, Thomas C, Federico A, Nemes K, Johann P, Bison B, Bens S, Dahlum S, Kordes U, Redlich A, Lessel L, Pajtler K, Mawrin C, Schüller U, Nolte K, Kramm C, Hinz F, Sahm F, Giannini C, Penkert J, Kratz C, Pfister S, Siebert R, Paulus W, Kool M, Frühwald M
AM J SURG PATHOL. 2022;46(9):1277-1283.

ALK inhibition as a salvage therapy for a relapsed unclassifiable sarcomatous CNS tumor with EML4/ALK fusion in an infant
Holsten T, Bronsema A, Sturm D, Sahm F, Rutkowski S, Ulrich S, Wößmann W, Kordes U
PEDIATR BLOOD CANCER. 2022;69(8):.

Infants and Newborns with Atypical Teratoid Rhabdoid Tumors (ATRT) and Extracranial Malignant Rhabdoid Tumors (eMRT) in the EU-RHAB Registry: A Unique and Challenging Population
Nemes K, Johann P, Steinbügl M, Gruhle M, Bens S, Kachanov D, Teleshova M, Hauser P, Simon T, Tippelt S, Eberl W, Chada M, Lopez V, Grigull L, Hernáiz-Driever P, Eyrich M, Pears J, Milde T, Reinhard H, Leipold A, van de Wetering M, Gil-da-Costa M, Ebetsberger-Dachs G, Kerl K, Lemmer A, Boztug H, Furtwängler R, Kordes U, Vokuhl C, Hasselblatt M, Bison B, Kröncke T, Melchior P, Timmermann B, Gerss J, Siebert R, Frühwald M
CANCERS. 2022;14(9):.

Genotype-phenotype associations within the Li-Fraumeni spectrum: a report from the German Registry
Penkert J, Strüwe F, Dutzmann C, Doergeloh B, Montellier E, Freycon C, Keymling M, Schlemmer H, Sänger B, Hoffmann B, Gerasimov T, Blattmann C, Fetscher S, Frühwald M, Hettmer S, Kordes U, Ridola V, Kroiss Benninger S, Mastronuzzi A, Schott S, Nees J, Prokop A, Redlich A, Seidel M, Zimmermann S, Pajtler K, Pfister S, Hainaut P, Kratz C
J HEMATOL ONCOL. 2022;15(1):.

Coping with Diffuse Intrinsic Pontine Glioma in Children - Findings from an Interview Study on Bereaved Parents
Radlanski K, Hartwig M, Kordes U
KLIN PADIATR. 2022;234(6):374-381.

Final results of the Choroid Plexus Tumor study CPT-SIOP-2000
Wolff J, Van Gool S, Kutluk T, Diez B, Kebudi R, Timmermann B, Garami M, Sterba J, Fuller G, Bison B, Kordes U
J NEURO-ONCOL. 2022;156(3):599-613.

2021

Ex vivo testis explant culture of human testicular tissue
Aden N, Soave A, Kordes U, Bleeke M, Salzbrunn A, von Kopylow K
J Reprodmed Endokrinol. 2021;2020(17 (Supplementum 1), 39-40):.

SMARCA4-deficient rhabdoid tumours show intermediate molecular features between SMARCB1-deficient rhabdoid tumours and small cell carcinomas of the ovary, hypercalcaemic type
Andrianteranagna M, Cyrta J, Masliah-Planchon J, Nemes K, Corsia A, Leruste A, Holdhof D, Kordes U, Orbach D, Corradini N, Entz-Werle N, Pierron G, Castex M, Brouchet A, Weingertner N, Ranchère D, Fréneaux P, Delattre O, Bush J, Leary A, Frühwald M, Schüller U, Servant N, Bourdeaut F
J PATHOL. 2021;255(1):1-15.

Current recommendations for clinical surveillance and genetic testing in rhabdoid tumor predisposition: a report from the SIOPE Host Genome Working Group
Frühwald M, Nemes K, Boztug H, Cornips M, Evans D, Farah R, Glentis S, Jorgensen M, Katsibardi K, Hirsch S, Jahnukainen K, Kventsel I, Kerl K, Kratz C, Pajtler K, Kordes U, Ridola V, Stutz E, Bourdeaut F
FAM CANCER. 2021;20(4):305-316.

Genetic testing and surveillance in infantile myofibromatosis: a report from the SIOPE Host Genome Working Group
Hettmer S, Dachy G, Seitz G, Agaimy A, Duncan C, Jongmans M, Hirsch S, Kventsel I, Kordes U, de Krijger R, Metzler M, Michaeli O, Nemes K, Poluha A, Ripperger T, Russo A, Smetsers S, Sparber-Sauer M, Stutz E, Bourdeaut F, Kratz C, Demoulin J
FAM CANCER. 2021;20(4):327-336.

Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases
Holdhof D, Johann P, Spohn M, Bockmayr M, Safaei S, Joshi P, Masliah-Planchon J, Ho B, Andrianteranagna M, Bourdeaut F, Huang A, Kool M, Upadhyaya S, Bendel A, Indenbirken D, Foulkes W, Bush J, Creytens D, Kordes U, Frühwald M, Hasselblatt M, Schüller U
ACTA NEUROPATHOL. 2021;141(2):291-301.

Evidence for a low-penetrant extended phenotype of rhabdoid tumor predisposition syndrome type 1 from a kindred with gain of SMARCB1 exon 6
Kordes U, Mautner V, Oyen F, Hagel C, Hartmann C, Heuser M, Frühwald M, Hasselblatt M, Oehl-Huber K, Siebert R, Schneppenheim R, Schüller U
PEDIATR BLOOD CANCER. 2021;68(10):e29185.

Evidence for a low-penetrant extended phenotype of RTPS1 from a kindred with gain of SMARCB1 exon 6
Kordes U, Mautner V, Oyen F, Hagel C, Hartmann C, Heuser M, Frühwald M, Hasselblatt M, Oehl-Huber K, Siebert R, Schneppenheim R, Schüller U
2021.

Clinical and genetic risk factors define two risk groups of extracranial malignant rhabdoid tumours (eMRT/RTK)
Nemes K, Bens S, Kachanov D, Teleshova M, Hauser P, Simon T, Tippelt S, Woessmann W, Beck O, Flotho C, Grigull L, Driever P, Schlegel P, Khurana C, Hering K, Kolb R, Leipold A, Abbink F, Gil-Da-Costa M, Benesch M, Kerl K, Lowis S, Marques C, Graf N, Nysom K, Vokuhl C, Melchior P, Kröncke T, Schneppenheim R, Kordes U, Gerss J, Siebert R, Furtwängler R, Frühwald M
EUR J CANCER. 2021;142:112-122.

Inhibition of nuclear export restores nuclear localization and residual tumor suppressor function of truncated SMARCB1/INI1 protein in a molecular subset of atypical teratoid/rhabdoid tumors
Pathak R, Zin F, Thomas C, Bens S, Gayden T, Karamchandani J, Dudley R, Nemes K, Johann P, Oyen F, Kordes U, Jabado N, Siebert R, Paulus W, Kool M, Frühwald M, Albrecht S, Kalpana G, Hasselblatt M
ACTA NEUROPATHOL. 2021;142(2):361-374.

Malignant gliomas with H3F3A G34R mutation or MYCN amplification in pediatric patients with Li Fraumeni syndrome
Schoof M, Kordes U, Volk A, Al-Kershi S, Kresbach C, Schüller U
ACTA NEUROPATHOL. 2021;142(3):591-593.

Atypical Teratoid/Rhabdoid Tumor (AT/RT) With Molecular Features of Pleomorphic Xanthoastrocytoma
Thomas C, Federico A, Sill M, Bens S, Oyen F, Nemes K, Johann P, Hartmann C, Hartmann W, Sumerauer D, Paterno V, Samii A, Kordes U, Siebert R, Frühwald M, Paulus W, Kool M, Hasselblatt M
AM J SURG PATHOL. 2021;45(9):1228-1234.

Transposable element insertion as a mechanism of SMARCB1 inactivation in atypical teratoid/rhabdoid tumor
Thomas C, Oehl-Huber K, Bens S, Soschinski P, Koch A, Nemes K, Oyen F, Kordes U, Kool M, Frühwald M, Hasselblatt M, Siebert R
GENE CHROMOSOME CANC. 2021;60(8):586-590.

The genetic landscape of choroid plexus tumors in children and adults
Thomas C, Soschinski P, Zwaig M, Oikonomopoulos S, Okonechnikov K, Pajtler K, Sill M, Schweizer L, Koch A, Neumann J, Schüller U, Sahm F, Rauschenbach L, Keyvani K, Proescholdt M, Riemenschneider M, Segewiß J, Ruckert C, Grauer O, Monoranu C, Lamszus K, Patrizi A, Kordes U, Siebert R, Kool M, Ragoussis J, Foulkes W, Paulus W, Rivera B, Hasselblatt M
NEURO-ONCOLOGY. 2021;23(4):650-660.

2020

Infant high grade gliomas comprise multiple subgroups characterized by novel targetable gene fusions and favorable outcomes
Clarke M, Mackay A, Ismer B, Pickles J, Tatevossian R, Newman S, Bale T, Stoler I, Izquierdo E, Temelso S, Carvalho D, Molinari V, Burford A, Howell L, Virasami A, Fairchild A, Avery A, Chalker J, Kristiansen M, Haupfear K, Dalton J, Orisme W, Wen J, Hubank M, Kurian K, Rowe C, Maybury M, Crosier S, Knipstein J, Schuller U, Kordes U, Kram D, Snuderl M, Bridges L, Martin A, Doey L, Al-Sarraj S, Chandler C, Zebian B, Cairns C, Natrajan R, Boult J, Robinson S, Sill M, Dunkel I, Gilheeney S, Rosenblum M, Hughes D, Proszek P, MacDonald T, Preusser M, Haberler C, Slavc I, Packer R, Ng H, Caspi S, Popovic M, Faganel Kotnik B, Wood M, Baird L, Davare M, Solomon D, Olsen T, Brandal P, Farrell M, Cryan J, Capra M, Karremann M, Schittenhelm J, Schuhmann M, Ebinger M, Dinjens W, Kerl K, Hettmer S, Pietsch T, Andreiuolo F, Driever P, Korshunov A, Hiddingh L, Worst B, Sturm D, Zuckermann M, Witt O, Bloom T, Mitchell C, Miele E, Colafati G, Diomedi-Camassei F, Bailey S, Moore A, Hassall T, Lowis S, Tsoli M, Cowley M, Ziegler D, Karajannis M, Aquilina K, Hargrave D, Carceller F, Marshall L, von Deimling A, Kramm C, Pfister S, Sahm F, Baker S, Mastronuzzi A, Carai A, Vinci M, Capper D, Popov S, Ellison D, Jacques T, Jones D, Jones C
CANCER DISCOV. 2020;10(7):942-963.

Age and DNA-methylation subgroup as potential independent risk factors for treatment stratification in children with Atypical Teratoid/Rhabdoid Tumors (ATRT)
Frühwald M, Hasselblatt M, Nemes K, Bens S, Steinbügl M, Johann P, Kerl K, Hauser P, Quiroga E, Solano-Paez P, Biassoni V, Gil-da-Costa M, Perek-Polnik M, van de Wetering M, Sumerauer D, Pears J, Stabell N, Holm S, Hengartner H, Gerber N, Grotzer M, Boos J, Ebinger M, Tippelt S, Paulus W, Furtwängler R, Hernáiz-Driever P, Reinhard H, Rutkowski S, Schlegel P, Schmid I, Kortmann R, Timmermann B, Warmuth-Metz M, Kordes U, Gerss J, Nysom K, Schneppenheim R, Siebert R, Kool M, Graf N
NEURO-ONCOLOGY. 2020;22(7):1006–1017.

Epigenetics impacts upon prognosis and clinical management of choroid plexus tumors
Thomas C, Metrock K, Kordes U, Hasselblatt M, Dhall G
J NEURO-ONCOL. 2020;148(1):39-45.

Desmoplastic myxoid tumor, SMARCB1-mutant: clinical, histopathological and molecular characterization of a pineal region tumor encountered in adolescents and adults
Thomas C, Wefers A, Bens S, Nemes K, Agaimy A, Oyen F, Vogelgesang S, Rodriguez F, Brett F, McLendon R, Bodi I, Burel-Vandenbos F, Keyvani K, Tippelt S, Poulsen F, Lipp E, Giannini C, Reifenberger G, Kuchelmeister K, Pietsch T, Kordes U, Siebert R, Frühwald M, Johann P, Sill M, Kool M, von Deimling A, Paulus W, Hasselblatt M
ACTA NEUROPATHOL. 2020;139(2):277-286.

2019

Manifestations and Treatment of Adult-onset Symptomatic Optic Pathway Glioma in Neurofibromatosis Type 1
Mehlan J, Schüttauf F, Salamon J, Kordes U, Friedrich R, Mautner V
ANTICANCER RES. 2019;39(2):827-831.

Two molecularly distinct atypical teratoid/rhabdoid tumors (or tumor components) occurring in an infant with rhabdoid tumor predisposition syndrome 1
Thomas C, Knerlich-Lukoschus F, Reinhard H, Johann P, Sturm D, Sahm F, Bens S, Vogt J, Nemes K, Oyen F, Kordes U, Siebert R, Schneppenheim R, Messing-Jünger M, Pietsch T, von Deimling A, Paulus W, Pfister S, Kool M, Frühwald M, Hasselblatt M
ACTA NEUROPATHOL. 2019;137(5):847-850.

Phase I/II intra-patient dose escalation study of vorinostat in children with relapsed solid tumor, lymphoma, or leukemia
van Tilburg C, Milde T, Witt R, Ecker J, Hielscher T, Seitz A, Schenk J, Buhl J, Riehl D, Frühwald M, Pekrun A, Rossig C, Wieland R, Flotho C, Kordes U, Gruhn B, Simon T, Linderkamp C, Sahm F, Taylor L, Freitag A, Burhenne J, Foerster K, Meid A, Pfister S, Karapanagiotou-Schenkel I, Witt O
CLIN EPIGENETICS. 2019;11(1):188.

2018

Germline variants in SMARCB1 and other members of the BAF chromatin-remodeling complex across human disease entities: a meta-analysis
Holsten T, Bens S, Oyen F, Nemes K, Hasselblatt M, Kordes U, Siebert R, Frühwald M, Schneppenheim R, Schüller U
EUR J HUM GENET. 2018;26(8):1083-1093.

Group 3 medulloblastoma in a patient with a GYS2 germline mutation and glycogen storage disease 0a
Holsten T, Tsiakas K, Kordes U, Bison B, Pietsch T, Rutkowski S, Santer R, Schüller U
CHILD NERV SYST. 2018;34(3):581-584.

Differences in maxillomandibular morphology among patients with mucopolysaccharidoses I, II, III, IV and VI: a retrospective MRI study
Koehne T, Köhn A, Friedrich R, Kordes U, Schinke T, Muschol N, Kahl-Nieke B
CLIN ORAL INVEST. 2018;22(3):1541-1549.

Biological material collection to advance translational research and treatment of children with CNS tumours: position paper from the SIOPE Brain Tumour Group
Rutkowski S, Modena P, Williamson D, Kerl K, Nysom K, Pizer B, Bartels U, Puget S, Doz F, Michalski A, von Hoff K, Chevignard M, Avula S, Murray M, Schönberger S, Czech T, Schouten-van Meeteren A, Kordes U, Kramm C, van Vuurden D, Hulleman E, Janssens G, Solanki G, van Veelen M, Thomale U, Schuhmann M, Jones C, Giangaspero F, Figarella-Branger D, Pietsch T, Clifford S, Pfister S, Van Gool S
LANCET ONCOL. 2018;19(8):e419-e428.

2017

Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology
Ripperger T, Bielack S, Borkhardt A, Brecht I, Burkhardt B, Calaminus G, Debatin K, Deubzer H, Dirksen U, Eckert C, Eggert A, Erlacher M, Fleischhack G, Frühwald M, Gnekow A, Goehring G, Graf N, Hanenberg H, Hauer J, Hero B, Hettmer S, von Hoff K, Horstmann M, Hoyer J, Illig T, Kaatsch P, Kappler R, Kerl K, Klingebiel T, Kontny U, Kordes U, Körholz D, Koscielniak E, Kramm C, Kuhlen M, Kulozik A, Lamottke B, Leuschner I, Lohmann D, Meinhardt A, Metzler M, Meyer L, Moser O, Nathrath M, Niemeyer C, Nustede R, Pajtler K, Paret C, Rasche M, Reinhardt D, Rieß O, Russo A, Rutkowski S, Schlegelberger B, Schneider D, Schneppenheim R, Schrappe M, Schroeder C, von Schweinitz D, Simon T, Sparber-Sauer M, Spix C, Stanulla M, Steinemann D, Strahm B, Temming P, Thomay K, von Bueren A, Vorwerk P, Witt O, Wlodarski M, Wössmann W, Zenker M, Zimmermann S, Pfister S, Kratz C
AM J MED GENET A. 2017;173(4):1017-1037.

2016

Methylation profiling of choroid plexus tumors reveals 3 clinically distinct subgroups
Thomas C, Sill M, Ruland V, Witten A, Hartung S, Kordes U, Jeibmann A, Beschorner R, Keyvani K, Bergmann M, Mittelbronn M, Pietsch T, Felsberg J, Monoranu C, Varlet P, Hauser P, Olar A, Grundy R, Wolff J, Korshunov A, Jones D, Bewerunge-Hudler M, Hovestadt V, von Deimling A, Pfister S, Paulus W, Capper D, Hasselblatt M
NEURO-ONCOLOGY. 2016;18(6):790-6.

2015

Radiation therapy for choroid plexus carcinoma patients with Li-Fraumeni Syndrome: advantageous or detrimental?
Bahar M, Kordes U, Tekautz T, Wolff J
ANTICANCER RES. 2015;35(5):3013-3017.

High-resolution genomic analysis does not qualify atypical plexus papilloma as a separate entity among choroid plexus tumors
Japp A, Gessi M, Messing-Jünger M, Denkhaus D, Zur Mühlen A, Wolff J, Hartung S, Kordes U, Klein-Hitpass L, Pietsch T
J NEUROPATH EXP NEUR. 2015;74(2):110-20.

Strategies to improve the quality of survival for childhood brain tumour survivors
Tallen G, Resch A, Calaminus G, Wiener A, Leiss U, Pletschko T, Friedrich C, Langer T, Grabow D, Driever P, Kortmann R, Timmermann B, Pietsch T, Warmuth-Metz M, Bison B, Thomale U, Krauss J, Mynarek M, von Hoff K, Ottensmeier H, Frühwald M, Kramm C, Temming P, Müller H, Witt O, Kordes U, Fleischhack G, Gnekow A, Rutkowski S
EUR J PAEDIATR NEURO. 2015;19(6):619-39.

Pediatric atypical choroid plexus papilloma reconsidered: increased mitotic activity is prognostic only in older children
Thomas C, Ruland V, Kordes U, Hartung S, Capper D, Pietsch T, Gerß J, Wolff J, Paulus W, Hasselblatt M
ACTA NEUROPATHOL. 2015;129(6):925-7.

2014

High-dose chemotherapy (HDCT) with auto-SCT in children with atypical teratoid/rhabdoid tumors (AT/RT): a report from the European Rhabdoid Registry (EU-RHAB)
Benesch M, Bartelheim K, Fleischhack G, Gruhn B, Schlegel P, Witt O, Stachel K, Hauch H, Urban C, Quehenberger F, Massimino M, Pietsch T, Hasselblatt M, Giangaspero F, Kordes U, Schneppenheim R, Hauser P, Klingebiel T, Frühwald M
BONE MARROW TRANSPL. 2014;49(3):370-5.

Favorable outcome of patients affected by rhabdoid tumors due to rhabdoid tumor predisposition syndrome (RTPS)
Kordes U, Bartelheim K, Modena P, Massimino M, Biassoni V, Reinhard H, Hasselblatt M, Schneppenheim R, Frühwald M
PEDIATR BLOOD CANCER. 2014;61(5):919-21.

Choroid plexus carcinomas are characterized by complex chromosomal alterations related to patient age and prognosis
Ruland V, Hartung S, Kordes U, Wolff J, Paulus W, Hasselblatt M
GENE CHROMOSOME CANC. 2014;53(5):373-80.

Methylation of the hTERT promoter is frequent in choroid plexus tumors but not of independent prognostic value
Ruland V, Hartung S, Kordes U, Wolff J, Paulus W, Hasselblatt M
J NEURO-ONCOL. 2014;119(1):215-6.

Neuroonkologie
Rutkowski S, Hornung D, Kordes U, Kammler G, Hagel C, Löbel U, Ebinger M, Rössler J, Resch A, Linhart D
2014. Neuropädiatrie - Evidenzbasierte Therapie. Korinthenberg R, Panteliadis C, Hagel C (eds.). 2. ed. München: Elsevier, .

2013

Supra- and infratentorial pediatric ependymomas differ significantly in NeuN, p75 and GFAP expression
Hagel C, Treszl A, Fehlert J, Harder J, von Haxthausen F, Kern M, von Bueren A, Kordes U
J NEURO-ONCOL. 2013;112(2):191-7.

High-resolution genomic analysis suggests the absence of recurrent genomic alterations other than SMARCB1 aberrations in atypical teratoid/rhabdoid tumors.
Hasselblatt M, Isken S, Linge A, Eikmeier K, Jeibmann A, Oyen F, Nagel I, Richter J, Bartelheim K, Kordes U, Schneppenheim R, Frühwald M, Siebert R, Paulus W
GENE CHROMOSOME CANC. 2013;52(2):185-190.

2012

Targeted therapeutics in treatment of children and young adults with solid tumors: an expert survey and review of the literature.
Grunewald T, Greulich N, Kontny U, Frühwald M, Rutkowski S, Kordes U, Scheurlen W, Schmidt W, Stachel D, Metzler M, Mittler U, Graf N, Benesch M, Burdach S
KLIN PADIATR. 2012;224(3):124-131.

Loss of TP53 expression in immortalized choroid plexus epithelial cells results in increased resistance to anticancer agents
Krzyzankova M, Mertsch S, Koos B, Jeibmann A, Kruse A, Kordes U, Frühwald M, Wolff J, Paulus W, Hasselblatt M
J NEURO-ONCOL. 2012;109(3):449-55.

Mismatch repair deficiency: a temozolomide resistance factor in medulloblastoma cell lines that is uncommon in primary medulloblastoma tumours.
von Bueren A, Bacolod M, Hagel C, Heinimann K, Fedier A, Kordes U, Pietsch T, Koster J, Grotzer M, Friedman H, Marra G, Kool M, Rutkowski S
BRIT J CANCER. 2012;107(8):1399-1408.

Pediatric high grade glioma of the spinal cord: results of the HIT-GBM database.
Wolff B, Ng A, Roth D, Parthey K, Warmuth-Metz M, Eyrich M, Kordes U, Kortmann R, Pietsch T, Kramm C, Wolff J
J NEURO-ONCOL. 2012;107(1):139-146.

CPT SIOP
Wolff J, Hasselblatt M, Hartung S, Powell M, Garami M, Traunecker H, Thall P, Mahajan A, Kordes U, Sumerauer D
J NEURO-ONCOL. 2012;14:i153.

2011

Glioblastoma in childhood – Treatment and outcome of 7 patients
Burkhardt T, Emami P, Kordes U, Matschke J, Regelsberger J, Westphal M, Kammler G
2011. 62. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC) Joint Meeting mit der Polnischen Gesellschaft für Neurochirurgen (PNCH). .

A complex karyotype in an atypical teratoid/rhabdoid tumor: case report and review of the literature.
Coccé M, Lubieniecki F, Kordes U, Alderete D, Gallego M
J NEURO-ONCOL. 2011;104(1):375-380.

Ectopic craniopharyngioma.
Kordes U, Flitsch J, Hagel C, Goebell E, Schwarz R, Herberhold T, von Bueren A, Rutkowski S, Müller H
KLIN PADIATR. 2011;223(3):176-177.

SIOP-CPT-2000 update
Kordes U, Kutluk T, Hasselblatt M, Pietsch A, Thall P, Wolff J
2011. 62. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC) Joint Meeting mit der Polnischen Gesellschaft für Neurochirurgen (PNCH). .

Parvovirus B19 infection and autoimmune hepatitis in a child with sickle cell anemia.
Kordes U, Schneppenheim R, Briem-Richter A, Scherpe S, Schäfer H
PEDIATR BLOOD CANCER. 2011;56(2):323-324.

2010

Neonatal cholestasis and glucose-6-P-dehydrogenase deficiency.
Kordes U, Briem-Richter A, Santer R, Schäfer H, Singer D, Sonntag J, Steuerwald U, Schneppenheim R, Janka-Schaub G
PEDIATR BLOOD CANCER. 2010;54(5):758-760.

Neonatal cholestasis in glucose-6-phosphate dehydrogenase deficiency.
Kordes U, Briem-Richter A, Santer R, Schäfer H, Singer D, Sonntag J, Steuerwald U, Schneppenheim R, Janka-Schaub G
PEDIATR BLOOD CANCER. 2010;54(5):758-766.

Clinical and molecular features in patients with atypical teratoid rhabdoid tumor or malignant rhabdoid tumor.
Kordes U, Gesk S, Frühwald M, Graf N, Leuschner I, Hasselblatt M, Jeibmann A, Oyen F, Peters O, Pietsch T, Siebert R, Schneppenheim R
GENE CHROMOSOME CANC. 2010;49(2):176-181.

Germline nonsense mutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndrome.
Schneppenheim R, Frühwald M, Gesk S, Hasselblatt M, Jeibmann A, Kordes U, Kreuz M, Leuschner I, Subero M, Obser T, Oyen F, Oyen F, Vater I, Siebert R
AM J HUM GENET. 2010;86(2):279-284.

2009

ITI with high-dose FIX and combined immunosuppressive therapy in a patient with severe haemophilia B and inhibitor.
Beutel K, Hauch H, Rischewski J, Kordes U, Schneppenheim J, Schneppenheim R
HAMOSTASEOLOGIE. 2009;29(2):155-157.

Recurrent loss, but lack of mutations, of the SMARCB1 tumor suppressor gene in T-cell prolymphocytic leukemia with TCL1A-TCRAD juxtaposition.
Bug S, Dürig J, Oyen F, Klein-Hitpass L, Martin-Subero J, Harder L, Baudis M, Arnold N, Kordes U, Dührsen U, Schneppenheim R, Siebert R
CANCER GENET-NY. 2009;192(1):44-47.

Cribriform neuroepithelial tumor (CRINET): a nonrhabdoid ventricular tumor with INI1 loss and relatively favorable prognosis.
Hasselblatt M, Oyen F, Gesk S, Kordes U, Brigitte W, Bergmann M, Schmid H, Frühwald M, Schneppenheim R, Siebert R, Paulus W
J NEUROPATH EXP NEUR. 2009;68(12):1249-1255.

Neuroonkologie
Kammler G, Kordes U, Hornung D, LINHART D, Hagel C
2009. Neuropädiatrie - Evidenzbasierte Therapie. Elsevier: 215-239.

2008

Successful donor-lymphocyte infusion for extreme immune-hemolysis following unrelated BMT in a patient with X-linked chronic granulomatous disease and McLeod phenotype.
Kordes U, Binder T, Eiermann T, Hassenpflug-Diedrich B, Hassan M, Beutel K, Nagy M, Kabisch H, Schneppenheim R
BONE MARROW TRANSPL. 2008;42(3):219-220.

Erythrocytapheresis: Do Not Forget a Useful Therapy!
Ullrich H, Fischer R, Grosse R, Kordes U, Schubert C, Altstadt B, Andreu G
TRANSFUS MED HEMOTH. 2008;35(1):24-30.

2006

Ovarian small cell carcinoma of the hypercalcemic type in children and adolescents: a prognostically unfavorable but curable disease.
Distelmaier F, Calaminus G, Harms D, Sträter R, Kordes U, Fleischhack G, Göbel U, Schneider D
CANCER-AM CANCER SOC. 2006;107(9):2298-2306.

Non-linkage of familial rhabdoid tumors to SMARCB1 implies a second locus for the rhabdoid tumor predisposition syndrome.
Frühwald M, Hasselblatt M, Wirth S, Köhler G, Schneppenheim R, Subero J, Siebert R, Kordes U, Jürgens H, Vormoor J
PEDIATR BLOOD CANCER. 2006;47(3):273-278.

Expression of SOX9 and SOX10 in central neuroepithelial tumor.
Kordes U, Hagel C
J NEURO-ONCOL. 2006;80(2):151-155.

2005

Sox group E gene expression distinguishes different types and maturational stages of glial cells in developing chick and mouse.
Kordes U, Cheng Y, Scotting P
DEV BRAIN RES. 2005;157(2):209-213.

Long-term treatment with deferiprone in a L1 veteran.
Meo A, Ruggeri A, Rosa L, Angela M, Kordes U, Kordes U, Fischer R
EUR J HAEMATOL. 2005;74(6):523-525.

2004

Gingivitis as probable source of a thoracic actinomycosis due to Actinomyces israelii and Actinobacillus actinomycetemcomitans.
Kordes U, Beutel K, Cachovan G, Schäfer H, Helmke K, Sobottka I
ARCH DIS CHILD. 2004;89(10):895.

2002

Dose-reduced conditioning regimen followed by allogeneic stem cell transplantation in patients with myelofibrosis with myeloid metaplasia.
Hessling J, Kröger N, Werner M, Zabelina T, Hansen A, Kordes U, Ayuketang Ayuk F, Renges H, Panse J, Erttmann R, Zander A
BRIT J HAEMATOL. 2002;119(3):769-772.

Homozygous Factor V Leiden mutation in sickle cell anaemia.
Kordes U, Janka-Schaub G, Schneppenheim R
BRIT J HAEMATOL. 2002;116(1):236.

Long-term follow-up of allogeneic stem cell transplantation in patients with severe aplastic anemia after conditioning with cyclophosphamide plus antithymocyte globulin.
Kröger N, Zabelina T, Renges H, Krüger W, Kordes U, Rischewski J, Schrum J, Horstmann M, Ayuketang Ayuk F, Erttmann R, Kabisch H, Zander A
ANN HEMATOL. 2002;81(11):627-631.

[SQUID-biosusceptometry in iron overloaded patients with hematologic diseases]
Nielsen P, Kordes U, Fischer R, Engelhardt R, Janka-Schaub G
KLIN PADIATR. 2002;214(4):218-222.

2000

Transcription factor NF-kappaB is constitutively activated in acute lymphoblastic leukemia cells.
Kordes U, Krappmann D, Heissmeyer V, Ludwig W, Scheidereit C
LEUKEMIA. 2000;14(3):399-402.

1999

Molecular mechanisms of constitutive NF-kappaB/Rel activation in Hodgkin/Reed-Sternberg cells.
Krappmann D, Emmerich F, Kordes U, Scharschmidt E, Dörken B, Scheidereit C
ONCOGENE. 1999;18(4):943-953.

Letzte Aktualisierung aus dem FIS: 28.03.2024 - 04:42 Uhr